Literature DB >> 17609583

Identification of a key amino acid of the human 5-HT(2B) serotonin receptor important for sarpogrelate binding.

Habib Abul Muntasir1, Murad Hossain, Mohiuddin Ahmed Bhuiyan, Tadazumi Komiyama, Takashi Nakamura, Masanobu Ozaki, Takafumi Nagatomo.   

Abstract

Based on radio-ligand binding and molecular modeling studies, sarpogrelate shows a moderate selectivity for 5-HT(2B) versus 5-HT(2A) receptors. To confirm the modeling data of sarpogrelate to 5-HT(2B) receptors predicting interaction of sarpogrelate towards Asp135 in helix 3 of 5-HT(2B) receptors, we constructed and characterized the mutation of this residue by site-directed mutagenesis. The Asp135Ala mutant did not exhibit any affinity for [(3)H]rauwolscine. Therefore, it was not possible to find sarpogrelate affinity to the mutant using [(3)H]rauwolscine. The mutation also abolished agonist-stimulated inositol phosphates formation. These results provide evidence that Asp135 is important for the interaction between 5-HT(2B) receptors and sarpogrelate.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17609583     DOI: 10.1254/jphs.sc0060241

Source DB:  PubMed          Journal:  J Pharmacol Sci        ISSN: 1347-8613            Impact factor:   3.337


  4 in total

1.  (1R, 3S)-(-)-trans-PAT: a novel full-efficacy serotonin 5-HT2C receptor agonist with 5-HT2A and 5-HT2B receptor inverse agonist/antagonist activity.

Authors:  Raymond G Booth; Lijuan Fang; Yingsu Huang; Andrzej Wilczynski; Sashikala Sivendran
Journal:  Eur J Pharmacol       Date:  2009-05-03       Impact factor: 4.432

2.  Development and validation of quantitative structure-activity relationship models for compounds acting on serotoninergic receptors.

Authors:  Grażyna Zydek; Elżbieta Brzezińska
Journal:  ScientificWorldJournal       Date:  2012-04-24

3.  Inhibitory Effect of Serotonin Antagonist on Leukocyte-Endothelial Interactions In Vivo and In Vitro.

Authors:  Hiroshi Kataoka; Yuno Ariyama; Michiyo Deushi; Mizuko Osaka; Kosaku Nitta; Masayuki Yoshida
Journal:  PLoS One       Date:  2016-01-29       Impact factor: 3.240

4.  Inhibition of 5-Hydroxytryptamine Receptor 2B Reduced Vascular Restenosis and Mitigated the β-Arrestin2-Mammalian Target of Rapamycin/p70S6K Pathway.

Authors:  Yahan Liu; Zhipeng Wang; Jing Li; Yiqian Ban; Guangmei Mao; Man Zhang; Mo Wang; Yan Liu; Beilei Zhao; Qiang Shen; Qingbo Xu; Nanping Wang
Journal:  J Am Heart Assoc       Date:  2018-01-30       Impact factor: 5.501

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.